HB Wealth Management LLC Buys 1,499 Shares of Intuitive Surgical, Inc. $ISRG

HB Wealth Management LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 27,772 shares of the medical equipment provider’s stock after purchasing an additional 1,499 shares during the quarter. HB Wealth Management LLC’s holdings in Intuitive Surgical were worth $15,729,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Rockingstone Advisors LLC raised its holdings in Intuitive Surgical by 4.1% in the 4th quarter. Rockingstone Advisors LLC now owns 6,275 shares of the medical equipment provider’s stock worth $3,554,000 after purchasing an additional 248 shares during the period. Caprock Group LLC grew its stake in shares of Intuitive Surgical by 23.5% during the 4th quarter. Caprock Group LLC now owns 11,355 shares of the medical equipment provider’s stock valued at $6,431,000 after acquiring an additional 2,161 shares during the period. Kingswood Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 64.5% during the 4th quarter. Kingswood Wealth Advisors LLC now owns 3,575 shares of the medical equipment provider’s stock valued at $2,025,000 after acquiring an additional 1,402 shares during the period. M&T Bank Corp grew its stake in shares of Intuitive Surgical by 200.0% during the 4th quarter. M&T Bank Corp now owns 175,150 shares of the medical equipment provider’s stock valued at $99,198,000 after acquiring an additional 116,768 shares during the period. Finally, Salomon & Ludwin LLC grew its stake in shares of Intuitive Surgical by 18.4% during the 4th quarter. Salomon & Ludwin LLC now owns 225 shares of the medical equipment provider’s stock valued at $127,000 after acquiring an additional 35 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $483.62 on Thursday. The stock has a market cap of $171.75 billion, a P/E ratio of 58.62, a PEG ratio of 3.52 and a beta of 1.68. Intuitive Surgical, Inc. has a 1 year low of $427.84 and a 1 year high of $603.88. The firm’s 50 day moving average price is $477.54 and its 200-day moving average price is $515.41.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.96%. The firm had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter last year, the business posted $1.81 earnings per share. The company’s revenue for the quarter was up 23.0% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 8.16 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares of the company’s stock, valued at $326,673.60. This represents a 16.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 421 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. This trade represents a 50.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 32,943 shares of company stock worth $17,279,568. Insiders own 0.60% of the company’s stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 results materially beat expectations — revenue $2.77B (+23% y/y) and non?GAAP EPS $2.50 vs. consensus ~$2.08; company raised its full?year procedure growth guidance, which underpins upside to recurring instrument/consumable sales. Why Intuitive Surgical (ISRG) Stock Is Up Today
• Positive Sentiment: Procedure and platform adoption remain the growth engine: da Vinci procedures grew ~16%, Ion procedures ~39%, and management highlighted placements/usage for the new da Vinci 5 — supporting longer?term recurring revenue. Intuitive Announces First Quarter Earnings
• Positive Sentiment: Analysts reacted by raising some forecasts and price targets (Goldman, Baird among those nudging targets higher), and several firms reiterated Buy/Outperform ratings after the beat — providing further near?term support. Intuitive Surgical Analysts Boost Their Forecasts After Upbeat Q1 Earnings
• Positive Sentiment: Management emphasized expansion of digital and AI?enabled surgical capabilities and secured new FDA clearances — strategic catalytic items for long?term TAM expansion and higher?margin software/services revenue. Intuitive Surgical Balances Growth In AI Surgery With Cybersecurity Lessons
• Neutral Sentiment: Earnings call color: management raised its 2026 da Vinci procedure growth guide (roughly 13.5%–15.5%) and described international headwinds as manageable — positive directional detail but partly conservative on full?year trajectory. Intuitive Surgical Earnings Call Signals Robust Growth
• Negative Sentiment: The company disclosed a recent cyber incident described as contained with remediation underway — a reputational and operational risk that investors will watch for any customer or regulatory fallout. Intuitive Surgical Balances Growth In AI Surgery With Cybersecurity Lessons
• Negative Sentiment: Valuation and caution remain: several firms trimmed price targets or tempered estimates (Jefferies, TD Cowen and others adjusted targets), and some commentators warn investors not to overpay despite high?quality growth — keeping volatility likely. TD Cowen Adjusts Price Target on Intuitive Surgical

Wall Street Analyst Weigh In

Several brokerages have recently commented on ISRG. Argus decreased their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Truist Financial decreased their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research report on Wednesday, April 15th. HSBC raised their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research report on Monday, January 26th. Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. Finally, BTIG Research reaffirmed a “buy” rating and issued a $574.00 price objective on shares of Intuitive Surgical in a research note on Wednesday. Eighteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $586.70.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.